Beneficial effects of treatment of early subclinical rejection: A randomized study

Journal of the American Society of Nephrology

Volumn 9, Issue 11, 1998, Pages 2129-2134

  Rush, David N ^a,b   Nickerson, Peter ^a   Gough, James ^a   McKenna, Rachel ^a   Grimm, Paul ^a   Cheang, Mary ^a   Trpkov, Kiril ^b   Solez, Kim ^b   Jeffery, John ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Department of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; METHYLPREDNISOLONE SODIUM SUCCINATE; OKT 3; PREDNISONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT INFECTION; GRAFT REJECTION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031758130     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Paul L: Chronic renal transplant loss. Kidney Int 47: 1491-1499, 1995
2. Flechner S, Modlin C, Serrano D, Goldfarb D, Papajcik D, Mastroianni B, Goormastic M, Novick A: Determinants of chronic renal allograft rejection in cyclosporine-treated recipients. Transplantation 62: 1235-1241, 1996
3. Almond P, Matas A, Gillingham K, Dunn D, Payne W, Gores P, Gruessner R, Najarian J: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55: 752-757, 1993
4. Tesi R, Henry M, Elkhammas E, Ferguson R: Predictors of long-term primary cadaveric renal transplant survival. Clin Transplant 7: 345-352, 1993
5. Massy Z, Guijarro C, Wiederkehr M, Ma J, Kasiske B: Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors. Kidney Int 49: 518-524, 1996
6. Hunsicker L, Bennett L: Design of trials of methods to reduce late renal allograft loss: The price of success. Kidney Int 48: S120-S123, 1995
7. Isoniemi HM, Krogerus L, von Willebrand E, Taskinen E, Ahonen J, Hayry P: Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 41: 155-160, 1992
8. Roberti I, Panico M, Reisman L: Urine flow cytometry as a predictor of renal allograft function. Transplantation 63: 781-782, 1997
9. Tsamandas AC, Shapiro R, Jordan M, Demetris AJ, Randhawa PS: Significance of tubulitis in chronic allograft nephropathy: A clinicopathologic study. Clin Transplant 11: 139-141, 1997
10. Rush DN, Henry SF, Jeffery JR, Schroeder T, Gough J: Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 57: 208-211, 1994
11. Rush DN, Jeffery JR, Gough J: Sequential protocol biopsies in renal transplant patients: Clinico-pathologic correlations using the Banff schema. Transplantation 59: 511-514, 1995
12. Rush DN, Jeffery JR, Gough J: Protocol biopsies in stable renal transplant patients under triple immunosuppression: Results at 6 months. Transplant Proc 26: 2576, 1994
13. Solez K, Benediktsson H, Cavallo T, Croker B, Demetris AJ, Drachenberg C, Emancipator S, Furness P, Gaber LW, Gibson IW, Gough J, Gupta R, Halloran P, Hayry P, Kashgarian M, Marcussen N, Massy Z, Mihatsch M, Morozumi K, Noronha I, Olsen S, Papadimitriou J, Paul LC, Picken M, Racusen LC, Ramos E, Randhawa P, Rayner DC, Rush D, Sanfilippo F, Taskinen E, Trpkov K, Truong L, Yamaguchi Y, Yilmaz S: Report of the third Banff conference on allograft pathology on classification and lesion scoring in renal allograft pathology. Transplant Proc 28: 441-444, 1996
14. Nickerson P, Jeffery J, Gough J, McKenna R, Grimm P, Cheang M, Rush D: Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol 9: 482-487, 1998
15. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL: Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 63: 968-974, 1997
16. Halloran PF, Homik J, Goes N, Lui SL, Urmson J, Ramassar V, Cockfield SM: The "injury response:" A concept linking non-specific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 29: 79-81, 1997
17. Basadonna G, Matas A, Gillingham K, Payne W, Dunn D, Sutherland D, Gores P, Gruessner R, Najarian J: Early versus late acute renal allograft rejection: Impact on chronic rejection. Transplantation 55: 993-995, 1993
18. Leggat JE Jr, Ojo AO, Leichtman AB, Port FK, Wolfe RA, Turenne MN, Held PJ: Long-term renal allograft survival: Prognostic implication of the timing of acute rejection episodes. Transplantation 63: 1268-1272, 1997
19. Baldwin AS: The NF-κB and I-κB proteins: New discoveries and insights. Annu Rev Immunol 14: 649-681, 1996
20. Ghosh S, May MJ, Kopp EB: NF-κB and REL proteins: Evolutionary conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998
21. Auphan N, DiDonato JA, Rosette C, Helberg A, Karin M: Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IF-κB synthesis. Science 270: 286-290, 1995
22. Blackwell TS, Christman JW: The role of nuclear factor κB in cytokine gene regulation. Am J Respir Cell Mol Biol 17: 3-9, 1997